Labcorp Holdings Inc.
LHHealthcareNASDAQDiagnostics & Research · Last scanned May 29, 2026
Scan Results
Daily timeframeLabcorp Holdings Inc. provides laboratory services. With a market capitalization of $21.55B, it sits in large-cap territory. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.
Market Cap
$21.55B
Beta
0.88
P/E (TTM)
23.25
P/E (Fwd)
13.51
EPS (TTM)
$11.30
EPS (Fwd)
$19.44
ROE
11.1%
ROA
5.3%
Cash
$981.1M
Total Debt
$7.29B
Free CF
$1.14B
52W Change
5.5%
Annual Financials
Cash vs Debt
On the balance sheet, LH has $981.1M in cash with $7.29B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $1.14B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 11.1%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $11.86B to $13.95B.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Labcorp Holdings Inc.'s trajectory.